Filing Details
- Accession Number:
- 0001209191-15-046866
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-26 18:02:23
- Reporting Period:
- 2015-05-21
- Filing Date:
- 2015-05-26
- Accepted Time:
- 2015-05-26 18:02:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1353843 | Juergen Martens | 28903 North Avenue Paine Valencia CA 91355 | Corporate Vp And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2015-05-21 | 20,000 | $4.57 | 88,776 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchases of shares of common stock of MannKind Corporation (the "Company") reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the reporting person's sales, pursuant to a Rule 10b5-1 plan adopted on December 2, 2014, of shares of common stock of the Company at prices ranging from $6.45 to $6.585 on March 2, 2015. The reporting person has agreed to pay to the Company, upon settlement of the purchases reported herein, the profit deemed to be realized by the reporting person in connection with the short-swing transaction, less transaction costs.